Antipsychotic drugs and obesity: is prolactin involved?

作者: Trino Baptista , Anny Lacruz , Teraiza Meza , Quilianio Contreras , Carlos Delgado

DOI: 10.1177/070674370104600906

关键词:

摘要: Objectifs : Correler les indices anthropometriques [indice de masse corporelle (IMC) et rapport taille-hanche (RTH)] avec concentrations prolactine serique chez une population heterogene patients traites aux antipsychotiques (AP) typiques. Methodes Nous avons evalue l'IMC, le RTH la a jeun hospitalises (n = 105) externes =122) AP, recevant d'autres psychotropes (APT) 77), sujets exempts medicaments 33). Les avaient libre acces nourriture, tandis que l'echantillon se composait personnes ayant un regime alimentaire monotone quelque 2000 calories par jour. Resultats La avait correlation positive l'IMC tout groupe masculins AP (P 0,03) des hommes 0,053). Quant duree du traitement, sans interruption pendant plus d'un an 0, 023). Par contre, on observe tendance negative entre patientes traitees 0,08) Aucune significative, pas meme n'a ete observee autres groupes. Conclusions peut participer prise poids induite antipsychotiques, surtout hommes. Des etudes ulterieures devraient caracteriser periode d'effet maximum sur corporel durant traitement AP. populations specifiques, particulierement sensibles l'hyperprolactinemie pourraient aussi etre reperees. detectee femmes ressemble reaction attenuee dans l'obesite primaire grave.

参考文章(47)
Toshiya Matsuzaki, Keijiro Azuma, Minoru Irahara, Toshiyuki Yasui, Toshihiro Aono, Mechanism of anovulation in hyperprolactinemic amenorrhea determined by pulsatile gonadotropin-releasing hormone injection combined with human chorionic gonadotropin. Fertility and Sterility. ,vol. 62, pp. 1143- 1149 ,(1994) , 10.1016/S0015-0282(16)57176-3
R. Prager, A. Luger, G. Schernthaner, C. Punzengruber, Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo. Diabetologia. ,vol. 28, pp. 138- 142 ,(1985) , 10.1007/BF00273860
Keh-Chuan Loh, Allan H. Shlossberg, Roger S. Rittmasterr, Renn O. Holness, Giant Prolactinomas: A Retrospective Review Endocrinologist. ,vol. 6, pp. 257- 263 ,(1996) , 10.1097/00019616-199605000-00013
PG Kopelman, Physiopathology of prolactin secretion in obesity. International Journal of Obesity. ,vol. 24, ,(2000) , 10.1038/SJ.IJO.0801291
T. Baptista, Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatrica Scandinavica. ,vol. 100, pp. 3- 16 ,(1999) , 10.1111/J.1600-0447.1999.TB10908.X
Robby M. Steel, Eve C. Johnstone, Should the treatment of schizophrenia include old antipsychotic drugs? Current Psychiatry Reports. ,vol. 2, pp. 404- 409 ,(2000) , 10.1007/S11920-000-0023-5
M. C. Foss, F. J. A. Paula, G. M. G. F. Paccola, C. E. Piccinato, Peripheral glucose metabolism in human hyperprolactinaemia Clinical Endocrinology. ,vol. 43, pp. 721- 726 ,(1995) , 10.1111/J.1365-2265.1995.TB00541.X
NIRA BEN-JONATHAN, JOHN L. MERSHON, DONALD L. ALLEN, ROSEMARY W. STEINMETZ, Extrapituitary Prolactin: Distribution, Regulation, Functions, and Clinical Aspects* Endocrine Reviews. ,vol. 17, pp. 639- 669 ,(1996) , 10.1210/EDRV-17-6-639
R. Cabrera, P. Mayor, J. Fernández-Ruiz, C. Calle, Insulin binding and action on adipocytes from female rats with experimentally induced chronic hyperprolactinemia Molecular and Cellular Endocrinology. ,vol. 58, pp. 167- 173 ,(1988) , 10.1016/0303-7207(88)90151-7